1. Nie X, Deng W, Zhou H, Wang Z. Long noncoding RNA MCM3AP-AS1 attenuates sepsis-induced cardiomyopathy by improving inflammation, oxidative stress, and mitochondrial function through mediating the miR-501-3p/CADM1/STAT3 axis. Int Immunopharmacol 2024; 128: 111500.
2.
Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol 2021; 18: 424-434.
3.
Reil PM, Maghiar TT, Vîlceanu N, et al. Assessing the Role of Lipopolysaccharide (LPS) Receptor (CD14) in Septic Cardiomyopathy: The Value of Immunohistochemical Diagnostics. Diagnostics (Basel) 2022; 12: 781.
4.
Foster DM, Kellum JA. Endotoxic Septic Shock: Diagnosis and Treatment. Int J Mol Sci 2023; 24: 16185.
5.
Dong W, Chen J, Wang Y, et al. miR-206 alleviates LPS-induced inflammatory injury in cardiomyocytes via directly targeting USP33 to inhibit the JAK2/STAT3 signaling pathway. Mol Cell Biochem 2024; 479: 929-940.
6.
Hu X, Miao H. MiR-539-5p inhibits the inflammatory injury in septic H9c2 cells by regulating IRAK3. Mol Biol Rep 2022; 49: 121-130.
7.
Li X, Wang L, Ying X, et al. Electroacupuncture pre-treatment alleviates sepsis-induced cardiac inflammation and dysfunction by inhibiting the calpain-2/STAT3 pathway. Front Physiol 2022; 13: 961909.
8.
Urbahn MA, Kaup SC, Reusswig F, et al. Phospholipase D1 regulation of TNF-alpha protects against responses to LPS. Sci Rep 2018; 8: 10006.
9.
Lanspa MJ, Cirulis MM, Wiley BM, et al. Right Ventricular Dysfunction in Early Sepsis and Septic Shock. Chest 2021; 159: 1055-1063.
10.
Netti G S, Sangregorio F, Spadaccino F, et al. LPS removal reduces CD80-mediated albuminuria in critically ill patients with Gram-negative sepsis. Am J Physiol Renal Physiol 2019; 316: F723-F731.
11.
Wu M, Li G, Wang W, Ren H. Emerging roles of microRNAs in septic cardiomyopathy. Front Pharmacol 2023; 14: 1181372.
12.
Dos Santos CC, Amatullah H, Vaswani C M, et al. Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury. Eur Respir J 2022; 59: 2004216.
13.
Zhang L, Li B, Li W, et al. miR-107 Attenuates Sepsis-Induced Myocardial Injury by Targeting PTEN and Activating the PI3K/AKT Signaling Pathway. Cells Tissues Organs 2023; 212: 523-534.
14.
Cao Y-Y, Wang Z, Wang Z-H, Jiang XG, Lu WH. Inhibition of miR-155 alleviates sepsis-induced inflammation and intestinal barrier dysfunction by inactivating NF-kB signaling. Int Immunopharmacol 2021; 90: 107218.
15.
Liu Z, Yang D, Gao J, et al. Discovery and validation of miR- 452 as an effective biomarker for acute kidney injury in sepsis. Theranostics 2020; 10: 11963-11975.
16.
Guan K, Liu S, Duan K, et al. Hsa_circ_0008259 modulates miR-21-5p and PDCD4 expression to restrain osteosarcoma progression. Aging (Albany NY) 2021; 13: 25484-25495.
17.
Sun L-H, Tian D, Yang Z-C, Li JL. Exosomal miR-21 promotes proliferation, invasion and therapy resistance of colon adenocarcinoma cells through its target PDCD4. Sci Rep 2020; 10: 8271.
18.
Farasati Far B, Vakili K, Fathi M, Yaghoobpoor S, Bhia M, Naimi-Jamal MR. The role of micro-RNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: A review. Life Sci 2023; 316: 121340.
19.
Jansing J C, Fiedler J, Pich A, et al. miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung Injury. Int J Mol Sci 2020; 21: 822.
20.
Xue Z, Xi Q, Liu H, et al. miR-21 promotes NLRP3 inflammasome activation to mediate pyroptosis and endotoxic shock. Cell Death Dis 2019; 10: 461.
21.
Surina S, Fontanella RA, Scisciola L, Marfella R, Paolisso G, Barbieri M. miR-21 in Human Cardiomyopathies. Front Cardiovasc Med 2021; 8: 767064.
22.
Zhang Z, Chen X, Gao B, et al. PLD1 knockdown reduces metastasis and inflammation of fibroblast-like synoviocytes in rheumatoid arthritis by modulating NF-kB and Wnt/b-catenin pathways. Autoimmunity 2021; 54: 398-405.
